PCRECEP Stock Latest News
Private CompaniesReceptor.AI to Examine Peptide Permeability Optimization5h agoRECEP
Private CompaniesRECEPTORAI Showcases ForceFold Platform for More Reliable Cyclic Peptide Modeling3d agoRECEP
Private CompaniesRECEPTORAI Highlights Conformation-Aware Approach to Peptide Permeability Optimization6d agoRECEP
Private CompaniesRECEPTORAI Highlights Peptide Discovery Platform Advancements1w agoRECEP
Private CompaniesAI-Driven Peptide Design Platform Signals Drug Discovery Ambitions for RECEPTORAI2w agoRECEP
Private CompaniesRECEPTORAI Highlights Advancements in AI-Driven Peptide–Protein Modeling2w agoRECEP
Private CompaniesRECEPTORAI Highlights SaaS Peptide Discovery Platform in Upcoming Webinar3w agoRECEP- Private CompaniesRECEPTORAI Showcases Structure-Guided Platform for Peptide Drug Design3w agoRECEP
Private CompaniesRECEPTORAI Launches SaaS Peptide Discovery Platform Focused on Affinity Optimization1M agoRECEP
Private CompaniesRECEPTORAI Emphasizes Computational Design for Peptide-Based Protein Degraders1M agoRECEP
Private CompaniesRECEPTORAI Targets Advanced Modeling Challenges in Peptide Drug Design1M agoRECEP
Private CompaniesRECEPTORAI Showcases AI-Driven Platform for Structure-Guided Peptide Discovery1M agoRECEP
- Private CompaniesHybrid AI–Physics Approaches Emerge as Focus in GPCR Drug Discovery Modeling1M agoRECEP
- Private CompaniesRECEPTORAI Targets Business Development Opportunities at EFMC Medicinal Chemistry 20262M agoRECEP
Private CompaniesRECEPTORAI Enters Strategic Collaboration To Advance AI-Driven Peptide Drug Discovery3M agoRECEP